Athauda, D;
Foltynie, T;
(2016)
The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action.
Drug Discovery Today
, 21
(5)
pp. 802-818.
10.1016/j.drudis.2016.01.013.